Exposure and Response Prevention for Children and Adolescents with Tourette Syndrome Delivered via Web-Based Videoconference versus Face-to-Face Method
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Exposure and Response Prevention for Children and Adolescents with Tourette Syndrome Delivered via Web-Based Videoconference versus Face-to-Face Method. / Soerensen, Camilla Birgitte; Lange, Theis; Jensen, Sidsel Normann; Grejsen, Judy; Aaslet, Lone; Skov, Liselotte; Debes, Nanette Mol.
In: Neuropediatrics, Vol. 54, No. 2, 2023, p. 99-106.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Exposure and Response Prevention for Children and Adolescents with Tourette Syndrome Delivered via Web-Based Videoconference versus Face-to-Face Method
AU - Soerensen, Camilla Birgitte
AU - Lange, Theis
AU - Jensen, Sidsel Normann
AU - Grejsen, Judy
AU - Aaslet, Lone
AU - Skov, Liselotte
AU - Debes, Nanette Mol
PY - 2023
Y1 - 2023
N2 - Chronic tic disorders, such as Tourette syndrome, are characterized by motor and vocal tics. Tics present a considerable burden for some patients, and therefore, effective treatment is important. One evidence-based treatment option is a behavioral therapy called exposure and response prevention (ERP). Despite its effectiveness, access to ERP remains limited due to a lack of treatment sites. Web-based videoconferences can connect patients at home with a therapist located in the hospital, allowing for treatment delivery over a wide geographic area. The primary aim of this study was to compare the development of tics during and 1 year after ERP delivery, respectively, via web-based videoconferences and traditional face-to-face methods in a naturalistic setting. In total, 116 patients treated using either the face-to-face method ( n = 72) or web-based videoconferences ( n = 44) were included. The primary outcome measure was tic severity. In both training modalities, tic severity decreased during ERP and the effect lasted in the follow-up period. No statistically significant differences in tic severity between the training modalities were found at baseline, last training session, or at follow-up. Our results suggest that ERP delivered via web-based videoconferences is a good alternative to the traditional face-to-face method.
AB - Chronic tic disorders, such as Tourette syndrome, are characterized by motor and vocal tics. Tics present a considerable burden for some patients, and therefore, effective treatment is important. One evidence-based treatment option is a behavioral therapy called exposure and response prevention (ERP). Despite its effectiveness, access to ERP remains limited due to a lack of treatment sites. Web-based videoconferences can connect patients at home with a therapist located in the hospital, allowing for treatment delivery over a wide geographic area. The primary aim of this study was to compare the development of tics during and 1 year after ERP delivery, respectively, via web-based videoconferences and traditional face-to-face methods in a naturalistic setting. In total, 116 patients treated using either the face-to-face method ( n = 72) or web-based videoconferences ( n = 44) were included. The primary outcome measure was tic severity. In both training modalities, tic severity decreased during ERP and the effect lasted in the follow-up period. No statistically significant differences in tic severity between the training modalities were found at baseline, last training session, or at follow-up. Our results suggest that ERP delivered via web-based videoconferences is a good alternative to the traditional face-to-face method.
KW - exposure and response prevention
KW - behavioral therapy
KW - web-based videoconference
KW - Tourette syndrome
KW - telemedicine
KW - tics
KW - HABIT-REVERSAL
KW - BEHAVIOR-THERAPY
KW - TIC DISORDERS
KW - PILOT TRIAL
KW - PREVALENCE
KW - SCALE
KW - COMORBIDITIES
KW - POPULATION
KW - SEVERITY
U2 - 10.1055/a-1987-3205
DO - 10.1055/a-1987-3205
M3 - Journal article
C2 - 36423651
VL - 54
SP - 99
EP - 106
JO - Neuropediatrics
JF - Neuropediatrics
SN - 0174-304X
IS - 2
ER -
ID: 334002698